• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国西南地区幽门螺杆菌菌株的脂多糖 O 抗原特征。

Lipopolysaccharide O-antigen profiles of Helicobacter pylori strains from Southwest China.

机构信息

West China Marshall Research Center for Infectious Diseases, Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Division of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

出版信息

BMC Microbiol. 2023 Nov 22;23(1):360. doi: 10.1186/s12866-023-03116-0.

DOI:10.1186/s12866-023-03116-0
PMID:37993791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10664510/
Abstract

BACKGROUND

Helicobacter pylori lipopolysaccharide (LPS) structures vary among strains of different geographic origin. The aim of this study was to characterize the LPS O-antigen profiles of H. pylori strains isolated from Southwest China, and to further analyze the association of Lewis antigen expression with clinical outcomes and antibiotic resistance.

RESULTS

A total of 71 H. pylori isolates from Southwest China were included for LPS profiling by silver staining and Western blotting after SDS-PAGE electrophoresis. We demonstrated that all the clinical isolates had the conserved lipid A and core-oligosaccharide, whereas the O-antigen domains varied significantly among the isolates. Compared with the common presence of the glucan/heptan moiety in LPS O-antigen structure of European strains, the clinical isolates in this study appeared to lack the glucan/heptan moiety. The expression frequency of Le, Le, Le, and Le was 66.2% (47/71), 84.5% (60/71), 56.3% (40/71), and 31.0% (22/71), respectively. In total, the expression of type II Le and/or Le was observed in 69 (97.2%) isolates, while type I Le and/or Le were expressed in 49 (69.0%) isolates. No association of Lewis antigen expression with clinical outcomes or with antibiotic resistance was observed.

CONCLUSIONS

H. pylori strains from Southwest China tend to produce heptan-deficient LPS and are more likely to express type I Lewis antigens as compared with Western strains. This may suggest that H. pylori evolves to change its LPS structure for adaptation to different hosts.

摘要

背景

幽门螺杆菌脂多糖(LPS)结构在不同地理来源的菌株中存在差异。本研究旨在对来自中国西南地区的幽门螺杆菌菌株的 LPS O-抗原谱进行特征分析,并进一步分析Lewis 抗原表达与临床结局和抗生素耐药性的关系。

结果

共纳入 71 株来自中国西南地区的幽门螺杆菌分离株,通过 SDS-PAGE 电泳后的银染和 Western blot 分析 LPS 图谱。结果显示,所有临床分离株均具有保守的脂质 A 和核心寡糖,而 O-抗原结构域在分离株之间存在显著差异。与欧洲菌株 LPS O-抗原结构中常见的葡聚糖/庚烷部分相比,本研究中的临床分离株似乎缺乏葡聚糖/庚烷部分。Le、Le、Le 和 Le 的表达频率分别为 66.2%(47/71)、84.5%(60/71)、56.3%(40/71)和 31.0%(22/71)。总的来说,69 株(97.2%)分离株表达了 II 型 Le 和/或 Le,49 株(69.0%)分离株表达了 I 型 Le 和/或 Le。未观察到 Lewis 抗原表达与临床结局或与抗生素耐药性有关。

结论

与西方菌株相比,来自中国西南地区的幽门螺杆菌菌株倾向于产生缺乏庚烷的 LPS,并且更可能表达 I 型 Lewis 抗原。这可能表明幽门螺杆菌为了适应不同的宿主而进化改变其 LPS 结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/385b38d39dba/12866_2023_3116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/3924e4affaf2/12866_2023_3116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/d3b44ca983cd/12866_2023_3116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/a10ff2c234a4/12866_2023_3116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/5d08675b2810/12866_2023_3116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/385b38d39dba/12866_2023_3116_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/3924e4affaf2/12866_2023_3116_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/d3b44ca983cd/12866_2023_3116_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/a10ff2c234a4/12866_2023_3116_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/5d08675b2810/12866_2023_3116_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4239/10664510/385b38d39dba/12866_2023_3116_Fig5_HTML.jpg

相似文献

1
Lipopolysaccharide O-antigen profiles of Helicobacter pylori strains from Southwest China.中国西南地区幽门螺杆菌菌株的脂多糖 O 抗原特征。
BMC Microbiol. 2023 Nov 22;23(1):360. doi: 10.1186/s12866-023-03116-0.
2
Helicobacter pylori isolates from Greek children express type 2 and type 1 Lewis and α1,6-glucan antigens in conjunction with a functional type IV secretion system.希腊儿童分离的幽门螺杆菌菌株与功能性 IV 型分泌系统一起表达 2 型和 1 型 Lewis 及α1,6-葡聚糖抗原。
J Med Microbiol. 2012 Apr;61(Pt 4):559-566. doi: 10.1099/jmm.0.038729-0. Epub 2011 Dec 8.
3
Analysis of Helicobacter pylori isolates from Chile: occurrence of selective type 1 Lewis b antigen expression in lipopolysaccharide.智利幽门螺杆菌分离株分析:脂多糖中选择性1型Lewis b抗原表达的情况
J Med Microbiol. 2008 May;57(Pt 5):585-591. doi: 10.1099/jmm.0.47783-0.
4
Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan.日本胃十二指肠疾病患者分离的幽门螺杆菌菌株脂多糖与Lewis抗原单克隆抗体的反应性
Clin Diagn Lab Immunol. 1997 Sep;4(5):540-4. doi: 10.1128/cdli.4.5.540-544.1997.
5
Expression of histo-blood group antigens by lipopolysaccharides of Helicobacter pylori strains from asian hosts: the propensity to express type 1 blood-group antigens.亚洲宿主幽门螺杆菌菌株脂多糖的组织血型抗原表达:表达1型血型抗原的倾向
Glycobiology. 2000 Jul;10(7):701-13. doi: 10.1093/glycob/10.7.701.
6
Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis(x) and Lewis(y) expression by H. Pylori lipopolysaccharides.幽门螺杆菌脂多糖与人胃上皮细胞表面糖型之间分子模拟的表型变异。幽门螺杆菌脂多糖诱导的Lewis(x)和Lewis(y)表达的酸诱导相变。
J Biol Chem. 2002 Feb 22;277(8):5785-95. doi: 10.1074/jbc.M108574200. Epub 2001 Dec 7.
7
The relationship between O-chain expression and colonisation ability of Helicobacter pylori in a mouse model.幽门螺杆菌O抗原链表达与小鼠模型中定殖能力的关系
FEMS Immunol Med Microbiol. 2000 Dec;29(4):263-70. doi: 10.1111/j.1574-695X.2000.tb01532.x.
8
The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains.幽门螺杆菌脂多糖O抗原和核心寡糖结构域的重新定义。
PLoS Pathog. 2017 Mar 17;13(3):e1006280. doi: 10.1371/journal.ppat.1006280. eCollection 2017 Mar.
9
East-Asian Helicobacter pylori strains synthesize heptan-deficient lipopolysaccharide.东亚地区的幽门螺杆菌菌株合成缺乏庚烷的脂多糖。
PLoS Genet. 2019 Nov 20;15(11):e1008497. doi: 10.1371/journal.pgen.1008497. eCollection 2019 Nov.
10
Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status.幽门螺杆菌分离株对人细胞表面糖缀合物Lewis x和Lewis y的表达与cagA状态有关。
Infect Immun. 1996 Nov;64(11):4598-605. doi: 10.1128/iai.64.11.4598-4605.1996.

引用本文的文献

1
Advances in Helicobacter pylori lipopolysaccharide structure and function.幽门螺杆菌脂多糖结构与功能的研究进展
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf034.
2
Development of a Recombinant Outer Membrane Vesicles (OMVs)-Based Vaccine Against Helicobacter pylori Infection in Mice.基于重组外膜囊泡(OMVs)的抗幽门螺杆菌感染小鼠疫苗的研发。
J Extracell Vesicles. 2025 May;14(5):e70085. doi: 10.1002/jev2.70085.
3
Knowledge, attitude, and practice toward Helicobacter pylori among residents in Northeast China‌.

本文引用的文献

1
Roles of Lipopolysaccharide Glycosyltransferases in Maintenance of Morphology, Cell Wall Permeability, and Antimicrobial Susceptibilities.脂多糖糖基转移酶在维持形态、细胞壁通透性和抗菌敏感性中的作用。
Int J Mol Sci. 2023 Jul 12;24(14):11381. doi: 10.3390/ijms241411381.
2
Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis.全球范围内 1980 年至 2022 年幽门螺杆菌感染的流行率:一项系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2023 Jun;8(6):553-564. doi: 10.1016/S2468-1253(23)00070-5. Epub 2023 Apr 20.
3
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship.
中国东北地区居民对幽门螺杆菌的认知、态度及行为
Sci Rep. 2025 May 1;15(1):15288. doi: 10.1038/s41598-025-00323-9.
4
Polysaccharides from Hua prevent depression-like behaviors in mice with chronic unpredictable mild stress through refining gut microbiota-lipopolysaccharide-paraventricular nucleus signal axis.来自桦的多糖通过优化肠道微生物群-脂多糖-室旁核信号轴预防慢性不可预测轻度应激小鼠的抑郁样行为。
Heliyon. 2024 Sep 26;10(19):e38554. doi: 10.1016/j.heliyon.2024.e38554. eCollection 2024 Oct 15.
5
High salt condition alters LPS synthesis and induces the emergence of drug resistance mutations in .高盐环境改变 LPS 合成并诱导 出现耐药突变。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0058724. doi: 10.1128/aac.00587-24. Epub 2024 Sep 6.
内毒素血症与胃肠道癌症:洞察危险关系背后的机制
Microorganisms. 2023 Jan 19;11(2):267. doi: 10.3390/microorganisms11020267.
4
Evaluation of a Molecular Mosprie Assay for Detection of Helicobacter pylori and Resistance to Clarithromycin and Levofloxacin.一种用于检测幽门螺杆菌及对克拉霉素和左氧氟沙星耐药性的分子Mosprie检测法的评估
J Infect Dis. 2022 Dec 8;226(Suppl 5):S503-S509. doi: 10.1093/infdis/jiac402.
5
Management of infection: the Maastricht VI/Florence consensus report.感染的管理:马斯特里赫特VI/佛罗伦萨共识报告
Gut. 2022 Aug 8. doi: 10.1136/gutjnl-2022-327745.
6
Susceptibility-guided bismuth quadruple therapies for resistant infections.药敏指导下的铋剂四联疗法治疗耐药感染。
Precis Clin Med. 2020 Jun;3(2):127-135. doi: 10.1093/pcmedi/pbaa010. Epub 2020 Mar 17.
7
infection is an infectious disease and the empiric therapy paradigm should be changed.感染是一种传染病,经验性治疗模式应该改变。
Precis Clin Med. 2019 Jun;2(2):77-80. doi: 10.1093/pcmedi/pbz009. Epub 2019 Jun 19.
8
and the Role of Lipopolysaccharide Variation in Innate Immune Evasion.以及脂多糖变异在固有免疫逃避中的作用。
Front Immunol. 2022 May 13;13:868225. doi: 10.3389/fimmu.2022.868225. eCollection 2022.
9
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing.需要标准化和协调幽门螺杆菌抗菌药物敏感性测试。
Helicobacter. 2022 Apr;27(2):e12873. doi: 10.1111/hel.12873. Epub 2022 Feb 12.
10
The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case-cohort study.在中国,幽门螺杆菌感染与贲门和非贲门胃癌的相对风险和归因风险:一项病例对照研究。
Lancet Public Health. 2021 Dec;6(12):e888-e896. doi: 10.1016/S2468-2667(21)00164-X.